Effect of anti-CD52 antibody alemtuzumab on <it>ex-vivo </it>culture of umbilical cord blood stem cells
<p>Abstract</p> <p>Background</p> <p>Excessive maturation of hematopoietic cells leads to a reduction of long-term proliferative capability during cord blood (CB) expansion. In this study, we report the effects of anit-CD52 (Alemtuzumab, Campath) on both short- and long...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-10-01
|
| Series: | Journal of Hematology & Oncology |
| Online Access: | http://www.jhoonline.org/content/1/1/19 |